The study population was characterized by a slight predominance of female (59%) and a marked predominance of stage IV (92%) and non-squamous histology (98%); two patients with squamous cell carcinoma and atypical clinical presentation for which clinicians had requested biomarker testing beyond PD-L1 were included. The gene discussed is CD274; the disease is squamous cell carcinoma.